A Novel PAK4 Inhibitor Suppresses Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine

0
118
Researchers developed a new PAK4 inhibitor, PAKib and tested its effect on pancreatic cancer (PC) cell growth in vitro and in a syngeneic mouse model of PC.
[Translational Oncology]
Full Article